Explore the words cloud of the GUTPEPTIDES project. It provides you a very rough idea of what is the project "GUTPEPTIDES" about.
The following table provides information about the project.
|Coordinator Country||Austria [AT]|
|Total cost||1˙487˙396 €|
|EC max contribution||1˙487˙396 € (100%)|
1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
|Duration (year-month-day)||from 2017-09-01 to 2022-08-31|
Take a look of project's partnership.
The gastrointestinal epithelium is a major physical barrier that protects us from diverse and potentially immunogenic or toxic content. A compromised epithelium results in increased permeability to such content, thus leading to inflammation, immune response, pain, and diseases, such as irritable bowel syndrome and inflammatory bowel disease. A therapeutic strategy that controls inflammation and restores the barrier represents an innovative approach for the prevention and treatment of such diseases. This proposal focuses on how gut peptides regulate epithelial protection and repair, and explores novel therapeutic opportunities by targeting gut receptors that become accessible once the epithelium is compromised. We propose to tackle the overall aim of improving gastrointestinal wound healing via three complementary objectives: (I) to investigate the therapeutic potential of the oxytocin receptor during gastrointestinal inflammation, (II) to elucidate the mechanism of trefoil factor peptide-induced gastrointestinal wound healing, and (III) to discover and characterise novel ligands suitable for epithelial repair. To achieve these objectives, we employ a multidisciplinary approach that includes state-of-the-art peptide synthesis, scaffold grafting, pharmacology, gut stability and wound healing assays, and inflammatory mouse models. We will develop probes to study the mechanisms of action at a molecular level that is not possible with current tools, and explore the biological diversity of venoms for novel therapeutic leads. This project will significantly advance our understanding of epithelial protection/repair and reveal drug targets that treat the source of the problems rather than the symptoms. This project has the potential to change the way we think about treating gut disorders and how to develop peptide therapeutics, and it will pave the way towards the intriguing and longer-term goal of modulating the central nervous system via the gut-brain axis.
|year||authors and title||journal||last update|
Zita LiutkeviÄiÅ«tÄ—, Esther Gil-Mansilla, Thomas Eder, Barbara Casillas-PÃ©rez, Maria Giulia Di Giglio, Edin MuratspahiÄ‡, Florian Grebien, Thomas Rattei, Markus Muttenthaler, Sylvia Cremer, Christian W. Gruber
Oxytocin-like signaling in ants influences metabolic gene expression and locomotor activity
published pages: 6808-6821, ISSN: 0892-6638, DOI: 10.1096/fj.201800443
|The FASEB Journal 32/12||2019-05-23|
Anne C. Conibear, Markus Muttenthaler
Advancing the Frontiers of Chemical Protein Synthesisâ€”The 7th CPS Meeting, Haifa, Israel
published pages: 247-254, ISSN: 2451-9456, DOI: 10.1016/j.chembiol.2018.03.001
|Cell Chemical Biology 25/3||2019-05-23|
Nayara Braga Emidio, Werner Hoffmann, Stuart M. Brierley, Markus Muttenthaler
Trefoil Factor Family: Unresolved Questions and Clinical Perspectives
published pages: 387-390, ISSN: 0968-0004, DOI: 10.1016/j.tibs.2019.01.004
|Trends in Biochemical Sciences 44/5||2019-05-23|
Volker Herzig, Aline de Araujo, Kathryn Greenwood, Yanni Chin, Monique Windley, Youmie Chong, Markus Muttenthaler, Mehdi Mobli, Neil Audsley, Graham Nicholson, Paul Alewood, Glenn King
Evaluation of Chemical Strategies for Improving the Stability and Oral Toxicity of Insecticidal Peptides
published pages: 90, ISSN: 2227-9059, DOI: 10.3390/biomedicines6030090
Sarah Arrowsmith, Peter Keov, Markus Muttenthaler, Christian W. Gruber
Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development
published pages: , ISSN: 1940-087X, DOI: 10.3791/56639
|Journal of Visualized Experiments 131||2019-05-23|
Markus Muttenthaler, Ã…sa Andersson, Irina Vetter, Rohit Menon, Marta Busnelli, Lotten Ragnarsson, Christian Bergmayr, Sarah Arrowsmith, Jennifer R. Deuis, Han Sheng Chiu, Nathan J. Palpant, Margaret Oâ€™Brien, Terry J. Smith, Susan Wray, Inga D. Neumann, Christian W. Gruber, Richard J. Lewis, Paul F. Alewood
Subtle modifications to oxytocin produce ligands that retain potency and improved selectivity across species
published pages: eaan3398, ISSN: 1937-9145, DOI: 10.1126/scisignal.aan3398
|Science Signaling 10/508||2019-05-23|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GUTPEPTIDES" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "GUTPEPTIDES" are provided by the European Opendata Portal: CORDIS opendata.
Towards Realistic Modelling of Nucleosome Organization Inside Functional Chromatin DomainsRead More
Discovery and Characterization of Hydrogen-Based High-Temperature SuperconductorsRead More
The Enemy of the Good: Towards a Theory of Moral ProgressRead More